These findings suggest that understanding the regulation of dynorphin/KOR systems in response to various stress exposures is critical to understanding and identifying KOR as a potentially novel therapeutic target system in drug relapse, anxiety, and depression. This evidence concerns the gene OPRK1 and major depressive disorder.